Replies to post #223580 on Biotech Values

[DewDiligence]

ENTA’s pro forma cash @3/31/19=$419.8M—an increase of $7.6M since 12/30/18 (#msg-146710290).

The $419.8M figure above consists of: $403.3 of net current assets on the 3/31/19 balance sheet (https://www.sec.gov/Archives/edgar/data/1177648/000156459019018517/enta-10q_20190331.htm#CONSOLIDATED_BALANCE_SHEETS ); and $16.5M of marketable securities on the 3/31/19 balance sheet designated as non-current (i.e. bonds with a maturity of >1 year).